Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending August 2012. The report details a specific share repurchase transaction executed on August 17, 2012, in accordance with shareholder authority granted at the Annual General Meeting on May 3, 2012.
Key Financial Metrics
The filing does not provide comprehensive financial statements such as revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on capital structure changes related to share buybacks.
- Shares Purchased: 750,000 Ordinary Shares of 25 pence each.
- Price Range: Highest price paid was 1,489 pence per share; lowest price paid was 1,464 pence per share.
- Treasury Holdings (Settled): 489,832,927 shares (8.95% of total issued share capital).
- Treasury Holdings (Including Unsettled): 491,782,927 shares (9.87% of current total voting rights).
- Shares in Issue (Excluding Treasury): 4,982,103,279 shares.
Material Changes
The primary material change reported is the reduction of outstanding shares through the purchase of 750,000 shares for Treasury. Consequently, the percentage of shares held in Treasury increased to 8.95% of total issued share capital, and the percentage of current total voting rights held in Treasury (including unsettled shares) reached 9.87%.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operational outlook, or discussion of risks and contingencies. It is a compliance disclosure confirming adherence to the Financial Services Authority's Disclosure and Transparency Rules. The text explicitly states that the announcement does not constitute an offer or solicitation to purchase securities.
Investor Verification Checklist
- Verify the total number of shares in issue (4,982,103,279) for calculating ownership thresholds under Disclosure and Transparency Rules.
- Confirm the updated Treasury share count (489,832,927 settled) for assessing dilution or buyback program progress.
- Note that this filing does not contain financial performance data; refer to Form 20-F or quarterly reports for revenue and earnings metrics.